
ART - antiretroviral therapy


Impact of HIV-status disclosure on HIV viral load in pregnant and postpartum women on antiretroviral therapy
Brittain K, Mellins CA, Remien RH, Phillips TK, Zerbe A, Abrams EJ, Myer L. J Acquir Immune Defic Syndr. 2019 Mar 29. doi: 10.1097/QAI.0000000000002036. [Epub ahead of print] Abstract BACKGROUND: HIV-status disclosure is widely encouraged by counselling...
Antiretroviral adherence, elevated viral load and drug resistant mutations in HIV-infected women initiating treatment in pregnancy: a nested case-control study
Myer L, Redd AD, Mukonda E, Lynch BA, Phillips TK, Eisenberg A, Hsiao NY, Capoferri A, Zerbe A, Clarke W, Lesosky M, Breaud A, McIntyre J, Bruno D, Martens C, Abrams EJ, Reynolds SJ. Clin Infect Dis. 2019 Mar 16. pii: ciz209. doi: 10.1093/cid/ciz209. [Epub ahead of...
January 2019: When starting ART in adults with advanced HIV disease and TB coinfection, prophylactic prednisone reduces risk of paradoxical TB-associated IRIS
Article and Study Summary Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS. Published in: N Engl J Med. 2018; 379:1915-1925. DOI: 10.1056/NEJMoa1800762 Authors: Meintjes G, Stek C, Blumenthal L, et al. Summary: This article reports on a...